ArticleStem cell research & therapy2021

Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.

Saeed Oraee-Yazdani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.